Speaker illustration

Doctor Ioannis Andrikou

Hippokration General Hospital, Athens (Greece)

Lipoprotein(a) and cardiovascular prognosis of familial dyslipidemias: data from a 10-year follow-up study

Event: ESC Congress 2024

Topic: Lipids

Session: Lp(a): the new risk factor

Thumbnail

Lipoprotein (a) and lipidemic parameters in PCSK-9 inhibitor patients. Experience from a specialized centre in Greece.

Event: ESC Congress 2024

Topic: Lipids

Session: Lp(a): the new risk factor

Thumbnail

Increased Lipoprotein (a) and familial hypercholesterolemia: a dangerous combination.Data from a 12-year follow-up study

Event: ESC Congress 2023

Topic: Lipids

Session: Risk factors and prevention: lipids (2)

Thumbnail

Microcirculation and blood pressure/heart rate response during exercise stress testing in hypertensive patients

Event: ESC Congress 2022

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension - Epidemiology, prognosis, outcome 2

Thumbnail

Lipoprotein (a) and new-onset type-2 diabetes in patients with familial combined hyperlipidemia: a 9 years follow-up study

Event: ESC Congress 2022

Topic: Lipids

Session: Lipids 3

Thumbnail

Correlation of lipoprotein (a) with parameters of lipid profile and other cardiovascular risk factors in patients with familial combined hyperlipidemia

Event: ESC Congress 2022

Topic: Lipids

Session: Lipids - Drug therapy 1

Thumbnail

An unusual case of myocarditis

Event: Heart Failure 2019

Topic: Clinical

Session: Clinical Cases

Thumbnail

Nocturnal hypertension versus Nondipping status for prediction of cardiac and renal alterations in hypertensives: a follow-up study

Event: ESC Congress 2017

Topic: Hypertension

Session: Detecting and stratifying hypertension

Thumbnail